Lin Hou

1.3k total citations
67 papers, 1.0k citations indexed

About

Lin Hou is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Lin Hou has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Physiology. Recurrent topics in Lin Hou's work include Neuroblastoma Research and Treatments (9 papers), Oral and Maxillofacial Pathology (8 papers) and Telomeres, Telomerase, and Senescence (7 papers). Lin Hou is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Oral and Maxillofacial Pathology (8 papers) and Telomeres, Telomerase, and Senescence (7 papers). Lin Hou collaborates with scholars based in China, United States and United Kingdom. Lin Hou's co-authors include Yinlin Ge, Yuan Dong, Jinbo Cheng, Xiaoheng Li, Yi Cao, Weijing Wang, Jinyu Zhang, Hua-Zhong Zhang, Shi‐Ming Tu and Mien‐Chie Hung and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Lin Hou

67 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Hou China 18 460 207 194 185 99 67 1.0k
Emma Robinson United Kingdom 22 800 1.7× 169 0.8× 254 1.3× 176 1.0× 94 0.9× 68 1.7k
Robert Murray United Kingdom 19 625 1.4× 118 0.6× 114 0.6× 174 0.9× 79 0.8× 44 1.4k
Naijin Zhang China 22 730 1.6× 177 0.9× 223 1.1× 141 0.8× 96 1.0× 71 1.3k
Xuefei Zhang China 18 523 1.1× 141 0.7× 267 1.4× 129 0.7× 335 3.4× 77 1.4k
Farzad Rahmani Iran 18 461 1.0× 211 1.0× 229 1.2× 61 0.3× 95 1.0× 56 1.0k
Feifei Ma China 21 621 1.4× 100 0.5× 297 1.5× 105 0.6× 76 0.8× 51 1.3k
Xudong Wang China 18 385 0.8× 220 1.1× 167 0.9× 76 0.4× 110 1.1× 59 1.1k
Zheng Lu China 20 458 1.0× 213 1.0× 192 1.0× 52 0.3× 149 1.5× 67 1.2k
José O. Alemán United States 16 572 1.2× 184 0.9× 130 0.7× 383 2.1× 100 1.0× 46 1.4k

Countries citing papers authored by Lin Hou

Since Specialization
Citations

This map shows the geographic impact of Lin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Hou more than expected).

Fields of papers citing papers by Lin Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Hou. The network helps show where Lin Hou may publish in the future.

Co-authorship network of co-authors of Lin Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Hou. A scholar is included among the top collaborators of Lin Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Hou. Lin Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yan, Pan Xiang, Xiaojiao Sun, et al.. (2024). Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy. Signal Transduction and Targeted Therapy. 9(1). 32–32. 4 indexed citations
2.
Liu, Xiaokun, Yuling Yang, Di Yang, et al.. (2024). EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis. APOPTOSIS. 29(7-8). 1161–1184. 4 indexed citations
3.
Song, Junying, Runze Wang, Lin Deng, et al.. (2023). Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin Resistance by Regulating AEG-1 Abundance in Breast Cancer Cells. Molecules. 28(7). 2939–2939. 5 indexed citations
4.
Xu, Chunjie, Lin Hou, Jing Zhao, et al.. (2022). Exosomal let-7i-5p from three-dimensional cultured human umbilical cord mesenchymal stem cells inhibits fibroblast activation in silicosis through targeting TGFBR1. Ecotoxicology and Environmental Safety. 233. 113302–113302. 39 indexed citations
5.
Wang, Lu, Peiyu Song, Cheng Cheng, et al.. (2021). The Added Value of Combined Timed Up and Go Test, Walking Speed, and Grip Strength on Predicting Recurrent Falls in Chinese Community-dwelling Elderly. Clinical Interventions in Aging. Volume 16. 1801–1812. 8 indexed citations
6.
Hou, Lin, Sichao Wang, Qing Chen, et al.. (2020). Associations of serum uric acid level with diabetic retinopathy and albuminuria in patients with type 2 diabetes mellitus. Journal of International Medical Research. 48(12). 1220763532–1220763532. 13 indexed citations
7.
Guo, Qingming, Peng Zhao, Zhen Zhang, et al.. (2020). TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of γδ T cells. Cancer Immunology Immunotherapy. 69(12). 2571–2587. 22 indexed citations
8.
Yang, Wei, Jianhua Liu, Lin Hou, Qingmin Chen, & Yahui Liu. (2020). Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line. Life Sciences. 265. 118796–118796. 23 indexed citations
9.
Zhang, Lu, Qian Tang, Ru Zhang, et al.. (2020). Hypomethylation of CTGF Promoter in Placenta and Peripheral Blood of Pre-eclampsia Women. Reproductive Sciences. 27(2). 468–476. 6 indexed citations
10.
Guo, Qingming, Zhen Zhang, Peng Zhao, et al.. (2019). Bispecific antibody activated T cells: A newly developed T cells with enhanced proliferation ability and cytotoxicity. Immunology Letters. 220. 79–87. 3 indexed citations
11.
Fu, Liyuan, Liye Jia, Peipei Han, et al.. (2017). Muscle strength rather than muscle mass is associated with osteoporosis in older Chinese adults. Journal of the Formosan Medical Association. 117(2). 101–108. 30 indexed citations
12.
Ma, Zhongliang, et al.. (2016). Decreased expression of the CHD5 gene and its clinicopathological significance in breast cancer: Correlation with aberrant DNA methylation. Oncology Letters. 12(5). 4021–4026. 9 indexed citations
13.
Xu, Pingping, Lin Hou, Zheng Zhang, et al.. (2016). Isatin inhibits the proliferation and invasion of SH-SY5Y neuroblastoma cells. Molecular Medicine Reports. 13(3). 2757–2762. 12 indexed citations
14.
Hou, Lin, et al.. (2013). Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo. European Journal of Pharmacology. 702(1-3). 235–241. 27 indexed citations
15.
Xue, Meilan, Qing Wang, Yinlin Ge, et al.. (2013). Docosahexaenoic acid inhibited the Wnt/β-Catenin pathway and suppressed breast cancer cells in vitro and in vivo. The Journal of Nutritional Biochemistry. 25(2). 104–110. 62 indexed citations
16.
Hou, Lin, et al.. (2013). Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer. Journal of Biomedical Science. 20(1). 52–52. 27 indexed citations
17.
Wang, Huali, et al.. (2012). [Aberrant expression and correlative analysis of P16 in breast cancers].. PubMed. 44(5). 755–9. 4 indexed citations
18.
Hou, Lin. (2011). Genetic Polymorphisms of methylenetetrahydrofolate reductase, methionine synthase, methylation of NF2, and their association with breast cancer mobidity. 3 indexed citations
19.
20.
Ge, Yinlin, et al.. (2009). The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells. International Immunopharmacology. 9(4). 389–395. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma Robinson Breakdown of academic impact, for papers by Robert Murray Breakdown of academic impact, for papers by Naijin Zhang Breakdown of academic impact, for papers by Xuefei Zhang Breakdown of academic impact, for papers by Farzad Rahmani Breakdown of academic impact, for papers by Feifei Ma Breakdown of academic impact, for papers by Xudong Wang Breakdown of academic impact, for papers by Zheng Lu Breakdown of academic impact, for papers by José O. Alemán
Rankless by CCL
2026